+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Route Of Administration (Injectable, Oral, Topical), Animal Type, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Veterinary Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Route Of Administration (Injectable, Oral, Topical), Animal Type, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Sale

Veterinary Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Route Of Administration (Injectable, Oral, Topical), Animal Type, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5532791
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Anti-infectives Market grew from USD 4.28 billion in 2024 to USD 4.81 billion in 2025. It is expected to continue growing at a CAGR of 12.07%, reaching USD 8.48 billion by 2030.

Laying the Groundwork for Veterinary Anti-infectives Market Analysis by Unveiling Core Dynamics and Strategic Imperatives

As the veterinary industry advances at a rapid pace, the anti-infectives sector stands at the forefront of innovation, regulatory scrutiny, and evolving stakeholder expectations. This introduction establishes foundational understanding by outlining the inherent challenges and emerging opportunities that define the current marketplace. With pathogens increasingly developing resistance and global health organizations reinforcing antimicrobial stewardship, industry stakeholders must balance the urgent need for effective treatments with stringent safety and efficacy requirements.

By situating veterinary anti-infectives within the broader context of animal health, this section underscores the interplay between technological breakthroughs in drug discovery, shifting supply chain paradigms, and the imperatives of sustainable usage. The convergence of digital tools for monitoring drug efficacy, advances in biologic therapies, and collaborative frameworks between public and private entities sets the stage for a nuanced analysis of how companies are pivoting strategies to meet both commercial and societal demands.

Exploring Pivotal Shifts Reshaping Veterinary Anti-infectives Landscape Through Technological Advances, Regulatory Changes and Evolving Stakeholder Expectations

In recent years, transformative shifts have disrupted the veterinary anti-infectives landscape, compelling organizations to reassess traditional business models and embrace new paradigms. Advances in molecular diagnostics now enable earlier detection of pathogens in livestock herds and companion animals, reducing treatment timelines and improving outcomes. Parallel to this, digital platforms facilitate real-time surveillance of antimicrobial resistance patterns, fostering data-driven stewardship and targeted therapy protocols.

Regulatory frameworks have also undergone significant revision, with authorities favoring transparent reporting, tighter residue limits, and phased reductions in certain antibiotic classes. Meanwhile, the rising emphasis on one-health initiatives has encouraged cross-sector collaboration, aligning veterinary practices with public health objectives. Collectively, these shifts are redefining value chains, prompting manufacturers and distributors to innovate around product formulations, delivery mechanisms, and service offerings tailored to evolving client needs.

Assessing the Cumulative Impact of 2025 United States Tariffs on Veterinary Anti-infectives Supply Chains, Cost Structures and Global Trade Dynamics

The introduction of new tariffs in the United States as of 2025 has exerted multifaceted pressure on global supply chains for veterinary anti-infectives, reshaping trade routes and cost structures. Higher import duties on active pharmaceutical ingredients sourced internationally have increased production expenses for domestic formulation facilities. In response, some manufacturers have revisited supplier agreements and logistics strategies to mitigate tariff burdens, while cash-flow management has become critical for maintaining competitive pricing.

Beyond direct cost implications, the tariff regime has catalyzed ripple effects across contract negotiations, inventory planning, and product shelf-life considerations. Companies with vertically integrated operations have leveraged internal manufacturing hubs to shield against volatility, whereas those reliant on external manufacturing partners have accelerated efforts to secure forward contracts. As importers and exporters adapt, the cumulative impact of these tariffs underscores the strategic importance of portfolio diversification and supply chain resilience in navigating an increasingly protectionist trade environment.

Illuminating Critical Segmentation Insights Across Product Types, Administration Routes, Animal Categories, Distribution Channels and Application Uses

When viewed through the lens of product type, the veterinary anti-infectives market is characterized by a broad array of solutions. Antibiotics span established classes such as aminoglycosides, beta-lactams, fluoroquinolones, macrolides, sulfonamides, and tetracyclines, each offering distinct mechanisms of action and spectrum coverage. Complementing this, antifungal agents are categorized into azoles and polyenes, while antiparasitic treatments include acaricides, anthelmintics, and insecticides designed to combat external and internal parasitic threats.

Evaluating routes of administration reveals a triad of injectable, oral, and topical formats. Injectable therapies are administered intramuscularly, intravenously, or subcutaneously to ensure rapid bioavailability; oral dosage forms such as pellets, powders, suspensions, and tablets enable convenient mass medication; and topical formulations encompassing creams, dips, ointments, and sprays address localized infections. Meanwhile, the market’s segmentation by animal type highlights aquaculture species like fish and shrimp, companion animals including cats and dogs, livestock such as cattle, goats, sheep, and swine, and poultry represented by chicken and turkey. Distribution channels range from online pharmacies and retail outlets to veterinary clinics and hospitals, while application divides into prophylactic preventive measures and therapeutic interventions.

Decoding Regional Variations in Veterinary Anti-infectives Demand and Distribution Trends Across the Americas, Europe Middle East Africa and Asia Pacific

Regional analysis reveals that the Americas continue to drive substantial demand for veterinary anti-infectives, supported by advanced pharmaceutical manufacturing infrastructures and a robust regulatory environment. North American markets benefit from established distribution networks and high adoption rates of digital health solutions, while Latin American regions are witnessing steady growth driven by expanding livestock operations and rising investment in veterinary healthcare services. Together, these dynamics underscore the strategic importance of the Western Hemisphere for manufacturers seeking scale and innovation.

In Europe, the Middle East and Africa, stringent antimicrobial stewardship policies coexist with diverse agricultural practices across member states and emerging economies. Western European countries are trailblazers in implementing prescription-only mandates and resistance monitoring, whereas Middle Eastern and African markets present opportunities through initiatives to enhance veterinary care accessibility. In the Asia-Pacific region, rapid expansion of aquaculture and intensification of livestock farming fuel market growth, with key markets adopting both domestic production capabilities and international partnerships to meet escalating demand for anti-infective solutions.

Highlighting Leading Industry Players’ Strategies, Innovations and Collaborative Ventures Driving Competitive Dynamics in Veterinary Anti-infectives Market

The competitive landscape in veterinary anti-infectives is shaped by a cohort of global and regional players pursuing differentiated growth strategies. Established pharmaceutical leaders have bolstered pipelines through targeted acquisitions and alliances, integrating novel active ingredients and biologic therapies to address emerging resistance profiles. Simultaneously, mid-sized firms are leveraging niche specializations in delivery technologies and formulation chemistries to carve out defensible market positions.

Innovation is further propelled by collaborative ventures between animal health specialists and biotechnology companies aiming to pioneer next-generation treatment modalities. These partnerships often focus on immunomodulatory compounds and vaccine adjuvants designed to reduce reliance on conventional antibiotics. Additionally, several companies have expanded their geographic footprint through strategic investment in local manufacturing and distribution channels, enhancing agility in responding to regional regulatory changes and supply chain disruptions.

Presenting Tailored Actionable Recommendations to Empower Industry Leaders in Enhancing Operational Resilience, Strategic Positioning and Value Creation

Industry leaders can enhance operational resilience by adopting integrated supply chain visibility tools that provide end-to-end tracking of ingredients and finished products. By investing in advanced analytics platforms, companies will be better positioned to anticipate disruptions, optimize inventory levels, and negotiate more favorable terms with suppliers. Embracing strategic partnerships with contract manufacturing organizations and third-party logistics providers can further mitigate risks associated with tariff fluctuations and regulatory shifts.

To strengthen market positioning, organizations should prioritize targeted research and development efforts in antimicrobial alternatives, including phage therapies and immunotherapeutics. Engaging in proactive dialogues with regulatory bodies and participating in industry consortia will accelerate alignment on stewardship guidelines while enhancing corporate reputation. Finally, embedding sustainability metrics throughout operations-ranging from green chemistry practices to environmentally responsible packaging-will resonate with stakeholders and support long-term value creation.

Detailing Rigorous Research Methodology Employed to Ensure Comprehensive Data Integrity, Robust Analysis and Insights Validity for Decision Makers

This research employed a multi-tiered methodology combining primary and secondary sources to ensure the accuracy and comprehensiveness of insights. Primary data was gathered through interviews with key opinion leaders, veterinary practitioners, and supply chain experts to validate emerging trends and evaluate the practical implications of regulatory changes. Secondary research encompassed peer-reviewed literature, industry whitepapers, and public filings, supplemented by proprietary databases to triangulate findings and identify data gaps.

Quantitative analysis was conducted using robust statistical techniques, including trend extrapolation and cross-segmentation correlation, to reveal how variables such as tariff adjustments and regional regulatory initiatives influence market dynamics. Qualitative assessments were integrated through thematic analysis of stakeholder interviews, adding depth to the narrative and ensuring that recommendations are grounded in real-world practice. Rigorous peer review protocols and iterative validation processes were applied throughout to maintain research integrity and support decision-grade reliability.

Synthesizing Key Findings and Strategic Imperatives to Offer a Holistic Perspective on the Future Trajectory of Veterinary Anti-infectives Sector

The convergence of technological innovation, regulatory evolution, and shifting stakeholder expectations is recalibrating the veterinary anti-infectives market; organizations that anticipate these dynamics and adapt with agility will achieve sustainable growth. Key themes emerging from this analysis underscore the importance of supply chain resilience, portfolio diversification across product classes and administration routes, and a heightened focus on antimicrobial stewardship to mitigate resistance risks.

Furthermore, regional nuances-from the advanced markets of North America and Western Europe to the rapidly scaling operations in Asia-Pacific-require tailored market entry and expansion strategies. By synthesizing segmentation insights and tariff impact assessments, this report offers a holistic framework for stakeholders to navigate complexity, seize emerging opportunities, and forge partnerships that drive long-term value. In doing so, veterinary health leaders will be well positioned to deliver effective, responsible, and economically viable anti-infective solutions.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Antibiotics
      • Aminoglycosides
      • Beta Lactams
      • Fluoroquinolones
      • Macrolides
      • Sulfonamides
      • Tetracyclines
    • Antifungals
      • Azoles
      • Polyenes
    • Antiparasitics
      • Acaricides
      • Anthelmintics
      • Insecticides
  • Route Of Administration
    • Injectable
      • Intramuscular
      • Intravenous
      • Subcutaneous
    • Oral
      • Pellets
      • Powders
      • Suspensions
      • Tablets
    • Topical
      • Creams
      • Dips
      • Ointments
      • Sprays
  • Animal Type
    • Aquaculture
      • Fish
      • Shrimp
    • Companion Animal
      • Cats
      • Dogs
    • Livestock
      • Cattle
      • Goats
      • Sheep
      • Swine
    • Poultry
      • Chicken
      • Turkey
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
    • Veterinary Clinics
    • Veterinary Hospitals
  • Application
    • Prophylactic
    • Therapeutic
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • C.H. Boehringer Sohn AG & Co. KG
  • Intas Pharmaceuticals Ltd.
  • Ceva Santé Animale SA
  • Vetoquinol SA
  • Eco Animal Health Group PLC
  • Virbac SA
  • Sequent Scientific Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising antimicrobial resistance driving demand for novel veterinary antibiotics and alternative therapies
5.2. Growth in precision livestock farming boosting targeted anti-infective delivery technologies
5.3. Increasing regulatory scrutiny on antibiotic use fueling adoption of bacteriophage therapies
5.4. Surge in companion animal healthcare spending driving innovation in species-specific anti-infectives
5.5. Widespread adoption of veterinary vaccines and immunomodulators reducing antibiotic reliance
5.6. Expansion of offshore veterinary biologics manufacturing enhancing supply chain resilience
5.7. Integration of point-of-care diagnostic tools with antibiotic stewardship programs in clinics
5.8. Development of long-acting injectable anti-infective formulations to improve treatment compliance
5.9. Rising investor interest in microbiome modulation therapies for livestock disease prevention
5.10. Implementation of digital monitoring platforms to track antibiotic usage and resistance trends on farms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Anti-infectives Market, by Product Type
8.1. Introduction
8.2. Antibiotics
8.2.1. Aminoglycosides
8.2.2. Beta Lactams
8.2.3. Fluoroquinolones
8.2.4. Macrolides
8.2.5. Sulfonamides
8.2.6. Tetracyclines
8.3. Antifungals
8.3.1. Azoles
8.3.2. Polyenes
8.4. Antiparasitics
8.4.1. Acaricides
8.4.2. Anthelmintics
8.4.3. Insecticides
9. Veterinary Anti-infectives Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.2.3. Subcutaneous
9.3. Oral
9.3.1. Pellets
9.3.2. Powders
9.3.3. Suspensions
9.3.4. Tablets
9.4. Topical
9.4.1. Creams
9.4.2. Dips
9.4.3. Ointments
9.4.4. Sprays
10. Veterinary Anti-infectives Market, by Animal Type
10.1. Introduction
10.2. Aquaculture
10.2.1. Fish
10.2.2. Shrimp
10.3. Companion Animal
10.3.1. Cats
10.3.2. Dogs
10.4. Livestock
10.4.1. Cattle
10.4.2. Goats
10.4.3. Sheep
10.4.4. Swine
10.5. Poultry
10.5.1. Chicken
10.5.2. Turkey
11. Veterinary Anti-infectives Market, by Distribution Channel
11.1. Introduction
11.2. Online Pharmacies
11.3. Retail Pharmacies
11.4. Veterinary Clinics
11.5. Veterinary Hospitals
12. Veterinary Anti-infectives Market, by Application
12.1. Introduction
12.2. Prophylactic
12.3. Therapeutic
13. Americas Veterinary Anti-infectives Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Veterinary Anti-infectives Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Veterinary Anti-infectives Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Zoetis Inc.
16.3.2. Elanco Animal Health Incorporated
16.3.3. Merck & Co., Inc.
16.3.4. C.H. Boehringer Sohn AG & Co. KG
16.3.5. Intas Pharmaceuticals Ltd.
16.3.6. Ceva Santé Animale SA
16.3.7. Vetoquinol SA
16.3.8. Eco Animal Health Group PLC
16.3.9. Virbac SA
16.3.10. Sequent Scientific Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VETERINARY ANTI-INFECTIVES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VETERINARY ANTI-INFECTIVES MARKET: RESEARCHAI
FIGURE 26. VETERINARY ANTI-INFECTIVES MARKET: RESEARCHSTATISTICS
FIGURE 27. VETERINARY ANTI-INFECTIVES MARKET: RESEARCHCONTACTS
FIGURE 28. VETERINARY ANTI-INFECTIVES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VETERINARY ANTI-INFECTIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ACARICIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ACARICIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INSECTICIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INSECTICIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PELLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PELLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DIPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DIPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY FISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SHRIMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SHRIMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GOATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GOATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SHEEP, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SHEEP, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CHICKEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CHICKEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TURKEY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TURKEY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 199. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 202. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 203. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 204. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 205. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 206. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 207. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 210. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 211. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 212. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 213. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 214. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 215. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 216. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 217. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 218. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 219. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
TABLE 220. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2025-2030 (USD MILLION)
TABLE 221. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 222. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 223. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 224. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 225. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 242. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 243. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 244. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 245. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
TABLE 250. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2025-2030 (USD MILLION)
TABLE 251. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 252. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 253. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 254. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 255. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 3

Samples

Loading
LOADING...

Companies Mentioned

  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • C.H. Boehringer Sohn AG & Co. KG
  • Intas Pharmaceuticals Ltd.
  • Ceva Santé Animale SA
  • Vetoquinol SA
  • Eco Animal Health Group PLC
  • Virbac SA
  • Sequent Scientific Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.48 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Veterinary Anti-Infectives Market Report 2025 - Product Image

Veterinary Anti-Infectives Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Veterinary Drug Market by Product Category (Anti-Infectives, Anti-Inflammatories, Parasiticides), Route Of Administration (Inhalation, Injectable, Oral), Animal Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Veterinary Drug Market by Product Category (Anti-Infectives, Anti-Inflammatories, Parasiticides), Route Of Administration (Inhalation, Injectable, Oral), Animal Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Veterinary Medicine Market by Animal Type (Companion Animal, Equine, Livestock), Product Type (Diagnostics, Medicated Feed Additives, Pharmaceuticals), Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast 2025-2030 - Product Image

Veterinary Medicine Market by Animal Type (Companion Animal, Equine, Livestock), Product Type (Diagnostics, Medicated Feed Additives, Pharmaceuticals), Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 258 Pages
  • Global
From
UK Veterinary Medicine Market Size, Share & Trends Analysis Report by Product (Biologics, Pharmaceutical), Animal Type (Production, Companion), Route of Administration, Distribution Channel, with Growth Forecasts, 2025-2030 - Product Image

UK Veterinary Medicine Market Size, Share & Trends Analysis Report by Product (Biologics, Pharmaceutical), Animal Type (Production, Companion), Route of Administration, Distribution Channel, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • United Kingdom
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.